What is the current share price of Jubilant Pharmova Limited (JUBLPHARMA)?

As of the latest market update, Jubilant Pharmova Limited (JUBLPHARMA) is trading at ₹976.75. The stock has moved 3.27% up in the recent session.

What is the technical sentiment for JUBLPHARMA stock?

Based on our proprietary technical analysis, the current signal for JUBLPHARMA is "NEUTRAL". This analysis considers over 20+ indicators including RSI, MACD, and moving average crossovers to gauge market momentum.

What is the 52-week high and low for Jubilant Pharmova Limited?

Jubilant Pharmova Limited has seen a 52-week high of ₹1,248 and a 52-week low of ₹786.05. Comparing the current price to these levels helps investors understand the stock's relative valuation and volatility over the past year.

Which sector does Jubilant Pharmova Limited belong to?

Jubilant Pharmova Limited operates in the Healthcare sector, specifically within the Pharmaceuticals & Biotechnology industry. Its performance is often influenced by broader trends in the Healthcare segment.

What is the market capitalization of JUBLPHARMA?

Jubilant Pharmova Limited (JUBLPHARMA) has a market capitalization of approximately ₹15.56K Cr. This classifies it as a small cap stock in the Indian market.

JUBLPHARMA

NSE

Jubilant Pharmova Limited (SMALL CAP)

Healthcare>Healthcare>Pharmaceuticals & Biotechnology>Pharmaceuticals

₹976.75

30.90 (3.27%)

High VOLATILITY

As on 12 Jun 2026

Advanced Chart

Price History

Market Cap

The total value of all a company's shares of stock. It's a quick way to gauge a company's size and value.

₹15.56K Cr

SMALL CAP

P/E Ratio

Price-to-Earnings ratio. It shows how much you pay for ₹1 of the company's earnings. A lower P/E might mean it's undervalued, but it varies by industry.

37.9

Industry

The specific business sector the company operates in. Useful for comparing with similar companies.

Pharmaceuticals

52-Week Range

The highest and lowest price at which the stock has traded in the last year (52 weeks). It helps show how volatile the stock is and where it is currently priced relative to its recent history.

52W Low₹786.05+24.3%

52W High₹1,248-21.7%

Current Price

₹976.75

Circuit Limits (20%)

The maximum allowed price movement (up or down) in a single trading day to prevent excessive volatility. If the stock hits these limits, trading may be temporarily halted.

Lower Circuit₹781.40

Upper Circuit₹1,172.10

Reference Price

₹976.75

Investment Checklist

Triple Top on 1D (BREAKOUT CONFIRMED) — target ₹1042.0

Triple Top on 1D (BREAKOUT CONFIRMED) — target ₹903.5

EMA(9) Crossover: Price crossed above EMA(9): Fresh bullish momentum signal.

EMA(20) Crossover: Price crossed above EMA(20): Fresh bullish momentum signal.

SuperTrend(10,3): Price above SuperTrend (Industry Standard (Swing/Medium-Term))

Technical Analysis

Analysis from 2026-06-12

Confidence

73%

Trend

NEUTRAL

Mixed MA signals — sideways/transition

EMA20

974.18

EMA50

956.37

EMA200

1004.29

Price Action

MIXED

NEUTRAL

Higher Highs3

Higher Lows4

Lower Highs6

Lower Lows5

Support & Resistance Levels

Resistance (Above)

₹998.35

₹1026.98

₹1060.00

₹1102.17

₹1144.67

Support (Below)

₹957.98

₹926.90

₹913.70

₹886.30

₹847.20

Volume Analysis

TrendDECREASING

Change-63.10%

Unusual VolumeNo

Stop Loss Levels

Fixed Risk

1% Risk₹966.98

3% Risk₹947.45

5% Risk₹927.91

7% Risk (Custom)

₹908.38

Technical Levels

1x ATR (Volatility)₹949.03

2x ATR (Swing)₹921.31

3x ATR (Trend)₹893.59

Immediate Support₹957.98

Moving Averages

EMA 9 (Short-term)₹970.13

EMA 20 (Medium-term)₹974.18

EMA 50 (Trend)₹956.37

Financials

Financial Analysis

Metric	Dec '24	Mar '25	Jun '25	Dec '25
Revenue	₹1,813.7 Cr	₹1,915.8 Cr	₹1,878.9 Cr	₹2,116.1 Cr
Net Profit	₹100.9 Cr	₹153.6 Cr	₹102.9 Cr	₹55.9 Cr
EPS	₹6.37	—	₹6.49	₹3.52
Operating Profit	₹277.4 Cr	₹334.5 Cr	₹301.5 Cr	₹270.2 Cr

Peer Comparison

Pharmaceuticals

Peer Comparison

Symbol	Name	Price	Change
SUNPHARMA	Sun Pharmaceutical Industries Limited	₹1,807.70	+0.75%
DIVISLAB	Divi's Laboratories Limited	₹6,638.00	-0.26%
TORNTPHARM	Torrent Pharmaceuticals Limited	₹4,571.20	-0.02%
CIPLA	Cipla Limited	₹1,389.40	+0.44%
ZYDUSLIFE	Zydus Lifesciences Limited	₹1,104.70	-0.11%
DRREDDY	Dr. Reddy's Laboratories Limited	₹1,275.40	-0.05%
LUPIN	Lupin Limited	₹2,293.30	+0.88%
MANKIND	Mankind Pharma Limited	₹2,381.10	+0.35%
AUROPHARMA	Aurobindo Pharma Limited	₹1,472.80	+0.59%
LAURUSLABS	Laurus Labs Limited	₹1,394.30	+0.25%

Corporate Information

Large Deals

View All

Bulk, Block and Short deals reported for this stock.

Loading Deals...

Corporate Actions

Recent actions

View All

Ex Date	Purpose	Type
25 Jul 2025	Dividend - Rs 5 Per Share	DIVIDEND
02 Aug 2024	Dividend - Rs 5 Per Share	DIVIDEND
10 Aug 2023	Dividend - Rs 5 Per Share	DIVIDEND
11 Aug 2022	Dividend - Rs 5 Per Share	DIVIDEND
05 Aug 2021	Dividend - Rs 5 Per Share	DIVIDEND

Announcements

Latest updates

View All

Date	Description	Link
30 May 2026	General Updates
28 May 2026	Analysts/Institutional Investor Meet/Con. Call Updates
23 May 2026	Copy of Newspaper Publication
23 May 2026	Analysts/Institutional Investor Meet/Con. Call Updates
23 May 2026	Pendency of Litigation(s)/dispute(s) or the outcome impacting the Company

Board Meetings

Upcoming and past meetings

View All

Date	Purpose	Links
22 May 2026	Financial Results/Dividend
22 May 2026	Board Meeting Intimation	XBRL
06 Feb 2026	Board Meeting Intimation	XBRL
06 Feb 2026	Financial Results
31 Oct 2025	Financial Results

Corporate Events

Upcoming results & meetings

View All

No upcoming events found

We couldn't find any scheduled corporate actions for this symbol at the moment.

Shareholding Pattern

As of Dec 2025Pledged: 5.40%

Current Distribution

Trend (Last 8 Qtrs)

Latest News

News for JUBLPHARMA

View All

Jubilant Pharmova Q4 profit declines on margin pressure; revenue rises 19%

positive

CNBC TV18 - Markets 22d ago

Jubilant Pharmova Q4 profit declines on margin pressure; revenue rises 19%

Jubilant Pharmova reported 19% revenue growth in Q4FY26, but weaker margins dragged profit lower. Shares turned volatile after earnings, while the company also announced a final dividend of ₹5 per share.

DIVIDENDJUBLPHARMAFinancial ServicesHealthcare

Read full story

Q4 Results LIVE Updates: Max Health shares decline 7%, Honasa Consumer up 7%; Hindalco report today

positive

CNBC TV18 - Markets 22d ago

Q4 Results LIVE Updates: Max Health shares decline 7%, Honasa Consumer up 7%; Hindalco report today

Q4 Results Live Update: Another busy earnings week ends with three Nifty names - Sun Pharma, Eicher Motors and Hindalco reporting their results today, along with broader market names like Torrent Pharma, Fortis Healthcare, DAM Capital, Colgate-Palmolive, IRCON International, Jubilant Pharmova, Minda Corp, and many others. LG, LIC, GAIL, ITC, will also be reacting to their results reported on Thursday.

ABSLBANETFABSLNN50ETABSLPSEAKCAPITAONETMMQ50AONETOTALAXISHCETFBSLNIFTYCOLPALCONSUMERCPCAPDAMCAPITALEICHERMOTFORTISGAILGROWWCAPMHCGHCG-REHEALTHADDHEALTHCAREHEALTHIETFHEALTHYHINDALCOHONASAIRCONITCJUBLCPLJUBLPHARMALICNETFN50LICNFNHGPLICNMID100MAXHEALTHMAXINDMEDANTAMINDACORPMOCAPITALMOMENTUMNIFTYQLITYPHARMABEESSANOFICONRSPARCTECHAutomobile and Auto ComponentsChemicals

Read full story

NEWS

negative

Business Standard - Markets 95d ago

Paras Defence and Space Technologies Ltd leads losers in 'A' group

KEI Industries Ltd, Jubilant Pharmova Ltd, Poly Medicure Ltd and Shree Renuka Sugars Ltd are among the other losers in the BSE's 'A' group today, 10 March 2026.

BSEDEFENCEJUBLPHARMAKEIPARASPOLYMEDRENUKACapital GoodsFast Moving Consumer Goods

Read full story

JUBLPHARMA

Price History

Investment Checklist

Technical Analysis

Technical Analysis

Trend

Price Action

Support & Resistance Levels

Volume Analysis

Stop Loss Levels

Fixed Risk

Technical Levels

Moving Averages

Financials

Financial Analysis

Peer Comparison

Peer Comparison

Corporate Information

Large Deals

Corporate Actions

Announcements

Board Meetings

Corporate Events

Shareholding Pattern

Shareholding Pattern

Current Distribution

Trend (Last 8 Qtrs)

Latest News

News for JUBLPHARMA

Jubilant Pharmova Q4 profit declines on margin pressure; revenue rises 19%

Q4 Results LIVE Updates: Max Health shares decline 7%, Honasa Consumer up 7%; Hindalco report today

Paras Defence and Space Technologies Ltd leads losers in 'A' group

Frequently Asked Questions

What is the current share price of Jubilant Pharmova Limited (JUBLPHARMA)?

What is the technical sentiment for JUBLPHARMA stock?

What is the 52-week high and low for Jubilant Pharmova Limited?

Which sector does Jubilant Pharmova Limited belong to?

What is the market capitalization of JUBLPHARMA?